drugset / Trial / NCT00952094
Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493
Phase 1
Completed
39 enrolled
Seoul National University Hospital
Jeil-Kirin Pharmaceutical Inc. · collabKyowa Hakko Kirin Pharma, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized, open, single ascending dose, parallel study to evaluate the pharmacokinetics, pharmacodynamics and safety of KRN1493 after single oral administration in healthy Korean male volunteers.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-01
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cinacalcet | Other / unclassified | 50 mg | Oral |
| Comparator | Cinacalcet | Other / unclassified | 75 mg | Oral |
| Comparator | Cinacalcet | Other / unclassified | 100 mg | Oral |
Indications
No indication recorded.